Latest in News & Research

Is NRS30 Valid for Assessing Treatment Effect for Hidradenitis Suppurativa Pain?

Achievement of NRS30 at week 16 associated with moderate-to-large improvements in clinical, patient-reported outcome measures

By Dermsquared Editorial Team | | August 23, 2023

Clascoterone Cream Safe, Efficacious for Moderate-to-Severe Acne

Long-term safety and efficacy favorable during treatment in patients aged 12 years and older with moderate-to-severe acne

By Dermsquared Editorial Team | | August 22, 2023

Long-Term Benefit Seen for Upadacitinib in Moderate-to-Severe AD

Patients switching from dupilumab to upadacitinib had additional incremental improvement in clinical response

By Dermsquared Editorial Team | | August 22, 2023

Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis

12 weeks of treatment also yields benefits in peak pruritus, change in SCORing Atopic Dermatitis

By Elana Gotkine (HealthDay News) | | August 22, 2023

Percentage of Women Mohs Fellows, Program Directors Has Increased

Significant positive trend seen between percentage of female representation and year since 1996

By Elana Gotkine (HealthDay News) | | August 18, 2023

Co-Occurrence of Psoriasis and Rheumatic Diseases Common

Psoriasis significantly linked to psoriatic arthritis, osteoarthritis, gout, fibromyalgia, RA, ankylosing spondylitis, Sjogren syndrome, systemic sclerosis

By Elana Gotkine (HealthDay News) | | August 18, 2023

Update on Pathogenesis of Vitiligo

Analyzing vitiligo’s complex pathways and exploring the convergence theory

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen, MD, MBA, MPH [1,2] | | August 15, 2023

Important Update

Winter Clinical Hawaii and Maui Wildfires

By Dermsquared Senior Clinical Advisors | | August 14, 2023

Model Predicts New Psoriatic Arthritis in People With Psoriasis

Model relies on readily available clinical variables

By Lori Solomon (HealthDay News) | | August 11, 2023

Is Uptitration of Baricitinib to 4 mg Beneficial for Severe Alopecia Areata?

25.9 percent of patients without response to baricitinib 2 mg achieved SALT score of 20 or lower after 24 weeks of 4 mg baricitinib

By Dermsquared Editorial Team | | August 10, 2023

Is Risankizumab Safe, Efficacious for Plaque Psoriasis in the Long Term?

Long-term treatment for up to five years was well tolerated and had high efficacy

By Dermsquared Editorial Team | | August 09, 2023

Reinforced Learning Model Can Improve Sensitivity of Skin Cancer Diagnosis

Correct diagnoses made by dermatologists increased with reinforcement learning, incorporating human preferences into AI model

By Elana Gotkine (HealthDay News) | | August 09, 2023

Higher Risk for Schizophrenia Seen Among Patients With Eczema

Authors say awareness of this association can aid collaborative patient care

By Lori Solomon (HealthDay News) | | August 08, 2023

Do Curettage and Cryosurgery Provide Clearance for Basal Cell Carcinomas?

Curettage and cryosurgery provide excellent clinical clearance rates with one and two free-thaw cycles in nonfacial basal cell carcinomas

By Dermsquared Editorial Team | | August 02, 2023

Do Clinical Symptoms Improve With Dupilumab in Bullous Pemphigoid?

Rapid and sustained improvement in clinical indicators and laboratory examination results seen after treatment

By Dermsquared Editorial Team | | August 02, 2023

Highlighting and Reviewing Recent Publications on Vitiligo

Navigate the latest insights in vitiligo with a comprehensive update on prevalence, pathogenesis, and treatments.

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen, MD, MBA, MPH [1,2] | | August 02, 2023

Illuminating the Path to Skin Repigmentation

Phototherapy for the Treatment of Vitiligo – What Every Dermatologist Should Know

By Charles Dunn, MD [1], Rajiv Nathoo, MD,1 Monique Kumar, MD [1] | | July 31, 2023

Low Vitamin D Levels Tied to Higher Severity of Psoriasis

Higher proportion of vitamin D deficiency seen among those with more body surface area affected by psoriasis

By Lori Solomon (HealthDay News) | | July 28, 2023

Review: Oral Isotretinoin Is Best Treatment for Acne

Meta-analysis reveals triple therapies containing topical retinoid, benzoyl peroxide, and antibiotic are next best

By Lori Solomon (HealthDay News) | | July 27, 2023

Variants at Two Loci Associated With Hidradenitis Suppurativa Risk

Two hidradenitis suppurativa-associated loci identified in meta-analysis of four studies, with variants located near SOX9 and KLF5 genes

By Dermsquared Editorial Team | | July 27, 2023

Incidence, Detection of Melanoma Low in Racial, Ethnic Minorities

Number needed to screen >12,000 in racial and ethnic minority individuals compared with 373 in non-Hispanic Whites

By Dermsquared Editorial Team | | July 26, 2023

LAUNCH ALERT: FDA Approves YCANTH for Molluscum Contagiosum

The groundbreaking topical solution addresses one of dermatology’s greatest unmet needs

By Dermsquared Editorial Team | | July 25, 2023

Melanoma Presentation, Mortality Varies by Race

Black patients face higher mortality with melanoma independent of insurance status and severity at diagnosis

By Lori Solomon (HealthDay News) | | July 24, 2023

24 of 1292

Headline from the Week of October 19 - 25, 2026

The Distance Between Habit and Strategy

By Dermsquared Editorial Team | | October 23, 2026

From Poster to Practice: The Control Gap in CIndU

| October 23, 2026